Antagonism of human platelet responses to stimulatory and inhibitory prostaglandins.

[1]  J. Mcgiff,et al.  6-Keto-prostaglandin E1 inhibits the aggregation of human platelets. , 1979, European journal of pharmacology.

[2]  O. V. Miller,et al.  Evidence for distinct prostaglandin I2 and D2 receptors in human platelets. , 1979, The Journal of pharmacology and experimental therapeutics.

[3]  K. C. Nicolaou,et al.  Selective binding site for [3H]prostacyclin on platelets. , 1979, The Journal of clinical investigation.

[4]  D. Macintyre,et al.  Effect on platelet activity of inhibition of adenylate cyclase. , 1978, Thrombosis research.

[5]  D. Macintyre,et al.  Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins. , 1978, The Biochemical journal.

[6]  A. Marcus.  The role of lipids in platelet function: with particular reference to the arachidonic acid pathway. , 1978, Journal of lipid research.

[7]  F. Fitzpatrick,et al.  A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors. , 1978, Biochimica et biophysica acta.

[8]  R. Lefkowitz,et al.  Identification of α-Adrenergic Receptors in Human Platelets by [3H]Dihydroergocryptine Binding , 1978 .

[9]  A. H. Drummond,et al.  Specific binding sites for 5-hydroxytryptamine on rat blood platelets , 1975 .

[10]  D. Macfarlane,et al.  Stimulation of human platelet adenylate cyclase by prostaglandin D2. , 1974, Thrombosis research.

[11]  P. Majerus,et al.  The binding of thrombin to the surface of human platelets. , 1974, The Journal of biological chemistry.

[12]  E. Salzman,et al.  Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function. , 1971, The Journal of clinical investigation.

[13]  J. Kloeze.  Relationship between chemical structure and platelet-aggregation activity of prostaglandins. , 1969, Biochimica et biophysica acta.